Suchergebnisse - "Castagna, Luca"

PubPharm (6)

1

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation : A report from the EBMT Lymphoma Working Party

enthalten in: Cancer | 2019

von Bazarbachi, A. | Boumendil, A. | Finel, H. | +23

2

Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide

enthalten in: Cancer | 2018

von Ruggeri, A. | Labopin, M. | Bacigalupo, A. | +11

3

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies

enthalten in: Cancer | 2015

von El-Cheikh, J. | Crocchiolo, R. | Furst, S. | +14

4

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

enthalten in: Cancer | 2013

von Crocchiolo, R. | Esterni, B. | Castagna, L. | +10

5

Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation : prospective clinical and socioeconomic evaluation

enthalten in: Cancer | 2013

von Blaise, D. | Tabrizi, R. | Boher, J. | +14

6

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation

enthalten in: Cancer | 2010

von Dodero, A. | Crocchiolo, R. | Patriarca, F. | +10

1
[1]